Concordant and Discordant Bone Marrow Involvement in Diffuse Large B-Cell Lymphoma: Are They Understudied Phenomena? Reply

被引：0
|
作者：
Gascoyne, Randy D. [1 ]
Scott, David W.
Sehn, Laurie H.
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 03期
关键词：
D O I：
10.1200/JCO.2011.38.5229
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：336 / 337
页数：3
相关论文
共 50 条
  • [1] Prognostic impact of concordant and discordant bone marrow involvement on diffuse large B-cell lymphoma
    Zuo, Huaqin
    Xie, Xiaoyan
    Sun, Xing
    Shi, Hanxue
    Pei, Xiaoping
    Sun, Mei
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (10) : 5339 - 5346
  • [2] Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP
    Sehn, Laurie H.
    Scott, David W.
    Chhanabhai, Mukesh
    Berry, Brian
    Ruskova, Anna
    Berkahn, Leanne
    Connors, Joseph M.
    Gascoyne, Randy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (11) : 1452 - 1457
  • [3] Prognostic Impact, Phenotypic and Molecular Characterization of Concordant and Discordant Bone Marrow Involvement in Patients with Diffuse Large b-Cell Lymphoma
    Alonso, Sara
    Alcoceba, Miguel
    Blanco, Oscar
    Davila, Julio
    Carlos Caballero, Juan
    Garcia, Luis
    Ferre, Oscar
    Lopez-Cadenas, Felix
    Arratibel, Nerea
    Veiga, Alvaro
    Baile, Monica
    Lopez, Oriana
    Perez, Estefania
    Dolores Caballero, Maria
    Gonzalez, Marcos
    Del Canizo, Consuelo
    Belen Vidriales, Maria
    Martin, Alejandro
    BLOOD, 2015, 126 (23)
  • [4] PROGNOSTIC IMPACT, PHENOTYPIC AND MOLECULAR CHARACTERIZATION OF CONCORDANT AND DISCORDANT BONE MARROW INVOLVEMENT IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Alonso, S.
    Alcoceba, M.
    Garcia-Alvarez, M.
    Caballero, J. C.
    Davila, J.
    Blanco, O.
    Caballero, M. D.
    Gonzalez, M.
    Gutierrez, N.
    Martin, A.
    HAEMATOLOGICA, 2016, 101 : 571 - 572
  • [5] Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP
    Shim, Hyoeun
    Oh, Jae-Il
    Park, Sang Hyuk
    Jang, Seongsoo
    Park, Chan-Jeoung
    Huh, Jooryung
    Suh, Cheolwon
    Chi, Hyun-Sook
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (05) : 420 - 425
  • [6] Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index
    Chung, Randy
    Lai, Raymond
    Wei, Peter
    Lee, Jason
    Hanson, John
    Belch, Andrew R.
    Turner, A. Robert
    Reiman, Tony
    BLOOD, 2007, 110 (04) : 1278 - 1282
  • [7] THE PROGNOSTIC IMPACT OF CONCORDANT AND DISCORDANT BONE MARROW INVOLVEMENT IN DIFFUSE LARGE B-CELL LYMPHOMA, INDEPENDENT OF THE REVISED INTERNATIONAL PROGNOSTIC INDEX AND CELL OF ORIGIN
    Park, M.
    Park, P.
    Seo, Y.
    Kim, K.
    Jeong, J.
    Kim, M.
    Ahn, J.
    Lee, J.
    Park, J.
    Hong, J.
    Kim, H.
    HAEMATOLOGICA, 2013, 98 : 147 - 147
  • [8] Prognostic impact of concordant and discordant bone marrow involvement and cell-of-origin in Korean patients with diffuse large B-cell lymphoma treated with R-CHOP
    Park, Mi-Jung
    Park, Soon-Ho
    Park, Pil-Whan
    Seo, Yiel-Hea
    Kim, Kyung-Hee
    Seo, Ja-Young
    Jeong, Ji-Hun
    Kim, Moon Jin
    Ahn, Jeong-Yeal
    Hong, Junshik
    JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (09) : 733 - 738
  • [9] Bone marrow involvement and outcome in Burkitt lymphoma and diffuse large B-cell lymphoma Response
    Jack, Andrew S.
    Barrans, Sharon L.
    Qian, Wendi
    Stenning, Sally P.
    Mead, Graham M.
    BLOOD, 2009, 114 (02) : 486 - 487
  • [10] Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome
    Chigrinova, Ekaterina
    Mian, Michael
    Scandurra, Marta
    Greiner, Timothy C.
    Chan, Wing C.
    Vose, Julie M.
    Inghirami, Giorgio
    Chiappella, Annalisa
    Baldini, Luca
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Franceschetti, Silvia
    Gaidano, Gianluca
    Tucci, Alessandra
    Facchetti, Fabio
    Lazure, Thierry
    Lambotte, Olivier
    Montes-Moreno, Santiago
    Piris, Miguel A.
    Nomdedeu, Josep Fr.
    Uccella, Silvia
    Rancoita, Paola M. V.
    Kwee, Ivo
    Zucca, Emanuele
    Bertoni, Francesco
    HEMATOLOGICAL ONCOLOGY, 2011, 29 (01) : 38 - 41
12345